Last updated 2026-06-18
- Raised $20M funding round, Jun 2017
- Raised funding round, Aug 2016
Total raised
$20.0M
Last: 2017-06
Stage
Series A
Founded
2016
Headcount
6
HQ
, Israel
Sector
Health Tech & Life Sciences
About
Mitoconix Bio is developing a strategy for improving mitochondrial health as a disease-modifying therapeutic for neurodegenerative diseases. The companys lead drug is an inhibitor of pathological mitochondrial fragmentation and dysfunction. The drug has demonstrated in vivo efficacy in animal models of Huntingtons disease and Parkinsons disease, and it has shown beneficial activity in patient-derived cells of Huntingtons disease, sporadic and genetic Parkinsons disease, and sporadic and genetic Alzheimers disease.
Funding history · 2 rounds · $20.0M total
2017-06
2016-08
Undisclosed
Q&A
- What is Mitoconix Bio's primary focus?
- Mitoconix Bio is developing therapeutics for neurodegenerative diseases, specifically focusing on improving mitochondrial health as a disease-modifying strategy.
- What is the status of Mitoconix Bio?
- Mitoconix Bio is currently inactive, having ceased operations in July 2019.
- When was Mitoconix Bio founded?
- Mitoconix Bio was founded in June 2016.
- What is Mitoconix Bio's lead drug candidate?
- Mitoconix Bio's lead drug is an inhibitor of pathological mitochondrial fragmentation and dysfunction, which has shown efficacy in animal models of Huntington's and Parkinson's disease, and in patient-derived cells for Huntington's and Parkinson's diseases.
- How much funding has Mitoconix Bio raised in total?
- Mitoconix Bio has raised a total of $20,000,000.
- When did Mitoconix Bio complete its last funding round?
- Mitoconix Bio completed its last funding round in June 2017, raising $20,000,000.
- Which investors participated in Mitoconix Bio's June 2017 funding round?
- The June 2017 funding round included investors such as RMGP Biopharma Investment Fund.
- How many employees did Mitoconix Bio have?
- Mitoconix Bio had 1-10 employees.
Team · 1
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
pharmaceuticalsneurologyalzheimers-diseaseparkinson
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2016-6 |
|---|---|
| Employees (exact) | 6 |
| Status reason | Non Active, Jul 2019 ceased to operate |